Calcitonin-specific transcription and splicing targets gene-directed enzyme prodrug therapy to medullary thyroid carcinoma cells

Journal of Clinical Endocrinology and Metabolism

Volumn 88, Issue 3, 2003, Pages 1310-1318

  Messina, Marinella ^a   Yu, Denise M T ^a   Both, Gerald W ^c   Molloy, Peter L ^c   Robinson, Bruce G ^a,b  

^a ROYAL NORTH SHORE HOSPITAL   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c CSIRO   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; CALCITONIN; CALCITONIN GENE RELATED PEPTIDE; FLUDARABINE; PURINE NUCLEOSIDE PHOSPHORYLASE; RECOMBINANT PROTEIN;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CELL SPECIFICITY; CONTROLLED STUDY; GENE THERAPY; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA SPLICING; THYROID MEDULLARY CARCINOMA;

ADENOVIRIDAE; CALCITONIN; CARCINOMA, MEDULLARY; GENE THERAPY; HUMANS; PRODRUGS; PROMOTER REGIONS (GENETICS); PURINE-NUCLEOSIDE PHOSPHORYLASE; RNA SPLICING; THYROID NEOPLASMS; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED; VIRUS REPLICATION;

ADENOVIRIDAE; ESCHERICHIA COLI;

EID: 0037339077     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2002-021501     Document Type: Article

References (54)

1. Messina M, Yu DM, Learoyd DL, Both GW, Molloy PL, Robinson BG 2000 High level, tissue-specific expression of a modified calcitonin/calcitonin gene-related peptide promoter in a human medullary thyroid carcinoma cell line. Mol Cell Endocrinol 164:219-224
2. Lausson S, Fournes B, Borrel C, Milhaud G, Treilhou-Lahille F 1996 Immune response against medullary thyroid carcinoma (MTC) induced by parental and/or interleukin-2-secreting MTC cells in a rat model of human familial medullary thyroid carcinoma. Cancer Immunol Immunother 43:116-123
3. Zhang R, Straus FH, DeGroot LJ 2001 Adenoviral-mediated gene therapy for thyroid carcinoma using thymidine kinase controlled by thyroglobulin promoter demonstrates high specificity and low toxicity. Thyroid 11:115-123
4. Zhang R, DeGroot LJ 2001 An adenoviral vector expressing functional heterogeneous proteins herpes simplex viral thymidine kinase and human interleukin-2 has enhanced in vivo antitumor activity against medullary thyroid carcinoma. Endocr Relat Cancer 8:315-325
5. Jiang S, Altmann A, Grimm D, Kleinschmidt JA, Schilling T, Germann C, Haberkorn U 2001 Tissue-specific gene expression in medullary thyroid carcinoma cells employing calcitonin regulatory elements and AAV vectors. Cancer Gene Ther 8:469-472
6. Parker WB, Allan PW, Shaddix SC, Rose LM, Speegle HF, Gillespie GY, Bennett Jr LL 1998 Metabolism and metabolic actions of 6-methylpurine and 2-fluoroadenine in human cells. Biochem Pharmacol 55:1673-1681
7. Martiniello-Wilks R, Tsatralis T, Russell P, Brookes DE, Zandvliet D, Lockett LJ, Both GW, Molloy PL, Russell PJ 2002 Transcription-targeted gene therapy for androgen-independent prostate cancer. Cancer Gene Ther 9:443-452
8. Latham JP, Searle PF, Mautner V, James ND 2000 Prostate-specific antigen promoter/enhancer driven gene therapy for prostate cancer: construction and testing of a tissue-specific adenovirus vector. Cancer Res 60:334-341
9. Park BJ, Brown CK, Hu Y, Alexander HR, Horti J, Raje S, Figg WD, Bartlett DL 1999 Augmentation of melanoma-specific gene expression using a tandem melanocyte-specific enhancer results in increased cytotoxicity of the purine nucleoside phosphorylase gene in melanoma. Hum Gene Ther 10:889-898
10. Kaneko S, Hallenbeck P, Kotani T, Nakabayashi H, McGarrity G, Tamaoki T, Anderson WF, Chiang YL 1975 Adenovirus-mediated gene therapy of hepatocellular carcinoma using cancer-specific gene expression. Cancer Res. 55:5283-5287
11. Osaki T, Tanio Y, Tachibana I, Hosoe S, Kumagai T, Kawase I, Oikawa S, Kishimoto T 1994 Gene therapy for carcinoembryonic antigen-producing human lung cancer cells by cell type-specific expression of herpes simplex virus thymidine kinase gene. Cancer Res 54:5258-5261
12. Rodriguez R, Schuur ER, Lim HY, Henderson GA, Simons JW, Henderson DR 1997 Prostate attenuated replication competent adenovirus (ARCA) CN706: a selective cytotoxic for prostate-specific antigen-positive prostate cancer cells. Cancer Res 57:2559-2563
13. Yu DC, Sakamoto GT, Henderson DR 1999 Identification of the transcriptional regulatory sequences of human kallikrein 2 and their use in the construction of calydon virus 764, an attenuated replication competent adenovirus for prostate cancer therapy. Cancer Res 59:1498-1504
14. Hallenbeck PL, Chang YN, Hay C, Golightly D, Stewart D, Lin J, Phipps S, Chiang YL 1999 A novel tumor-specific replication-restricted adenoviral vector for gene therapy of hepatocellular carcinoma. Hum Gene Ther 10:1721-1733
15. Doronin K, Kuppuswamy M, Toth K, Tollefson AE, Krajcsi P, Krougliak V, Wold WSM 2001 Tissue-specific, tumor-selective, replication-competent adenovirus vector for cancer gene therapy. J Virol 75:3314-3324
16. Savontaus MJ, Sauter BV, Huang TG, Woo SL 2002 Transcriptional targeting of conditionally replicating adenovirus to dividing endothelial cells. Gene Ther 9:972-979
17. Minemura K, Takeda T, Nagasawa T, Zhang R, Leopardi R, DeGroot LJ 2000 Cell-specific induction of sensitivity to ganciclovir in medullary thyroid carcinoma cells by adenovirus-mediated gene transfer of herpes simplex virus thymidine kinase. Endocrinology 141:1814-1822
18. Lou H, Gagel RF 1998 Alternative RNA processing-its role in regulating expression of calcitonin/calcitonin gene-related peptide. J Endocrinol 156:401-405
19. Lou H, Neugebauer KM, Gagel RF, Berget SM 1998 Regulation of alternative polyadenylation by U1 snRNPs and SRp20. Mol Cell Biol 18:4977-4985
20. Amara SG, Jonas V, Rosenfeld MG, Ong ES, Evans RM 1982 Alternative RNA processing in calcitonin gene expression generates mRNAs encoding different polypeptide products. Nature 298:240-244
21. Rosenfeld MG, Amara SG, Evans RM 1984 Alternative RNA processing: determining neuronal phenotype. Science 225:1315-1320
22. Zhang R, Minemura K, De Groot LJ 1998 Immunotherapy for medullary thyroid carcinoma by a replication-defective adenovirus transducing murine interleukin-2. Endocrinology 139:601-608
23. Zhang R, Straus FH, DeGroot LJ 1999 Effective genetic therapy of established medullary thyroid carcinomas with murine interleukin-2: dissemination and cytotoxicity studies in a rat tumor model. Endocrinology 140:2152-2158
24. Lockett LJ, Molloy PL, Russell PJ, Both GW 1997 Relative efficiency of tumor cell killing in vitro by two enzyme-pro-drug systems delivered by identical adenovirus vectors. Clin Cancer Res 3:2075-2080
25. van Oers CC, Adema GJ, Zandberg H, Moen TC, Baas PD 1994 Two different sequence elements within exon 4 are necessary for calcitonin-specific splicing of the human calcitonin/calcitonin gene-related peptide I pre-mRNA. Mol Cell Biol 14:951-960
26. Kozak M 1986 Point mutations define a sequence flanking the AUG initiator codon that modulates translation by eukaryotic ribosomes. Cell 44:283-292
27. Martiniello-Wilks R, Garcia-Aragon J, Daja MM, Russell P, Both GW, Moloy PL, Lockett LJ, Russell PJ 1998 In vivo gene therapy for prostate cancer: preclinical evaluation of two different enzyme-directed pro-drug therapy systems delivered by identical adenovirus vectors. Hum Gene Ther 9:1617-1626
28. Brookes DE, Zandvliet D, Watt F, Russell PJ, Molloy PL 1998 Relative activity and specificity of promoters from prostate-expressed genes. Prostate 35:18-26
29. Graham F, Prevec L 1991 Manipulation of adenovirus vectors. In: Murray EJ, ed. Gene transfer and expression protocols. Clifton, NJ: Humana Press; 109-128
30. Sorscher EJ, Peng S, Bebok Z, Allan PW, Bennett Jr LL, Parker WB 1994 Tumor cell bystander killing in colonic carcinoma utilizing the Escherichia coli DeoD gene to generate toxic purines. Gene Ther 1:233-238
31. Ivanchuk SM, Eng C, Cavenee WK, Mulligan LM 1997 The expression of RET and its multiple splice forms in developing human kidney. Oncogene 14:1811-1818
32. Zandberg H, Moen TC, Baas PD 1995 Cooperation of 5′ and 3′ processing sites as well as intron and exon sequences in calcitonin exon recognition. Nucleic Acids Res 23:248-255
33. van Oers CC, Bakker L, Baas PD 1994 The exon 4 poly(A) site of the human calcitonin/CGRP-I pre-mRNA is a weak site in vitro. Biochim Biophys Acta 1218:55-63
34. Bennett MM, Amara SG 1992 Molecular mechanisms of cell-specific and regulated expression of the calcitonin/α-CGRP and β-CGRP genes. Ann N Y Acad Sci 657:36-49
35. Adema GJ, van Hulst KL, Baas PD 1990 Uridine branch acceptor is a cis-acting element involved in regulation of the alternative processing of calcitonin/CGRP-I pre-mRNA. Nucleic Acids Res 18:5365-5373
36. Yeakley JM, Hedjran F, Morfin JP, Merillat N, Rosenfeld MG, Emeson RB 1993 Control of calcitonin/calcitonin gene-related peptide pre-mRNA processing by constitutive intron and exon elements. Mol Cell Biol 13:5999-6011
37. Cote GJ, Stolow DT, Peleg S, Berget SM, Gagel RF 1992 Identification of exon sequences and an exon binding protein involved in alternative RNA splicing of calcitonin/CGRP. Nucleic Acids Res 20:2361-2366
38. Lou H, Gagel RF, Berget SM 1996 An intron enhancer recognized by splicing factors activates polyadenylation. Genes Dev 10:208-219
39. Hedjran F, Yeakley JM, Huh GS, Hynes RO, Rosenfeld MG 1997 Control of alternative pre-mRNA splicing by distributed pentameric repeats. Proc Natl Acad Sci USA 94:12343-12347
40. Lou H, Cote GJ, Gagel RF 1994 The calcitonin exon and its flanking intronic sequences are sufficient for the regulation of human calcitonin/calcitonin gene-related peptide alternative RNA splicing. Mol Endocrinol 8:1618-1626
41. Zhang R, DeGroot LJ 2000 Gene therapy of established medullary thyroid carcinoma with herpes simplex viral thymidine kinase in a rat tumor model: relationship of bystander effect and antitumor efficacy. Thyroid 10:313-319
42. Mohr L, Shankara S, Yoon SK, Krohne TU, Geissler M, Roberts B, Blum HE, Wands JR 2000 Gene therapy of hepatocellular carcinoma in vitro and in vivo in nude mice by adenoviral transfer of the Escherichia coli purine nucleoside phosphorylase gene. Hepatology 31:606-614
43. Coleman TP, Roesser JR 1998 RNA secondary structure: an important cis-element in rat calcitonin/CGRP pre-messenger RNA splicing. Biochemistry 37:15941-15950
44. Cote GJ, Nguyen IN, Lips CJ, Berget SM, Gagel RF 1991 Validation of an in vitro RNA processing system for CT/CGRP precursor mRNA. Nucleic Acids Res 19:3601-3606
45. Roesser JR, Liittschwager K, Leff SE 1993 Regulation of tissue-specific splicing of the calcitonin/calcitonin gene-related peptide gene by RNA-binding proteins. J Biol Chem 268:8366-8375
46. Bovenberg RA, van de Meerendonk WP, Baas PD, Steenbergh PH, Lips CJ, Jansz HS 1986 Model for alternative RNA processing in human calcitonin gene expression. Nucleic Acids Res 14:8785-803
47. Lou H, Yang Y, Cote GJ, Berget SM, Gagel RF 1995 An intron enhancer containing a 5′ splice site sequence in the human calcitonin/calcitonin gene-related peptide gene. Mol Cell Biol 15:7135-7142
48. Adema GJ, Baas PD 1992 A novel calcitonin-encoding mRNA is produced by alternative processing of calcitonin/calcitonin gene-related peptide-I pre-mRNA. J Biol Chem 267:7943-7948
49. Minvielle S, Giscard-Dartevelle S, Cohen R, Taboulet J, Labye F, Jullienne A, Rivaille P, Milhaud G, Moukhtar MS, Lasmoles F 1991 A novel calcitonin carboxyl-terminal peptide produced in medullary thyroid carcinoma by alternative RNA processing of the calcitonin/calcitonin gene-related peptide gene. J Biol Chem 266:24627-24631
50. Bracq S, Taboulet J, Machairas M, Lasmoles F, Houssin D, Moukhtar MS, Jullienne A 1997 Calcitonin mRNA is produced in liver by two different splicing pathways. Mol Cell Endocrinol 128:111-115
51. Delsert CD, Rosenfeld MG 1992 A tissue-specific small nuclear ribonucleo-protein and the regulated splicing of the calcitonin/calcitonin gene-related protein transcript. J Biol Chem 267:14573-14579
52. Lou H, Helfman DM, Gagel RF, Berget SM 1999 Polypyrimidine tract-binding protein positively regulates inclusion of an alternative 3′-terminal exon. Mol Cell Biol 19:78-85
53. Crenshaw 3rd EB, Russo AF, Swanson LW, Rosenfeld MG 1987 Neuron-specific alternative RNA processing in transgenic mice expressing a metallothionein-calcitonin fusion gene. Cell 49:389-398
54. Yamazaki M, Zhang R, Straus FH, Messina M, Robison BG, Hashizume K, DeGroot LJ 2002 Effective gene therapy for medullary thyroid carcinoma using recombinant adenovirus inducing tumor-specific expression of interleukin-12. Gene Ther 9:64-74